Application of Auricular Point Sticking in Patients With Taste Alteration
Study On The Application of Auricular Point Sticking Based On Holographic Theory In Chemotherapy-related Taste Alterations In Cancer Patients
1 other identifier
interventional
120
1 country
1
Brief Summary
To explore the intervention effect of auricular point sticking on chemotherapy-induced taste alterations in cancer patients, and analyze its relationship with quality of life, nutritional status and psychology of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2023
CompletedFirst Posted
Study publicly available on registry
May 22, 2023
CompletedStudy Start
First participant enrolled
June 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJanuary 31, 2024
January 1, 2024
4 months
April 24, 2023
January 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Taste alterations
The Chinese version of the Chemotherapy-induced Taste Alteration Scale (CiTAS), was used to assess the patients' taste alterations. The scale has 18 items in three dimensions, namely taste alteration, unpleasant taste alteration, unpleasant symptoms and problems. The scale is a Like-5 scale with a minimum score of 18 and a maximum score of 90, with higher scores indicating more severe symptoms of taste alterations. The scale has been verified by research and has good reliability and validity.
T1: Baseline. T2:2 weeks. T3: 4 weeks. T4:5 weeks.
Secondary Outcomes (6)
Quality of life for cancer patients
T1: Baseline. T2:2 weeks. T3: 4 weeks. T4:5 weeks. T5:8 weeks.
Anxiety and depression
T1: Baseline. T2:2 weeks. T3:4 weeks. T4:5 weeks. T5:8 weeks.
Nutritional status 1
T1: baseline(Data were collected before the intervention). T2: 4 weeks. T3:8 weeks.
Nutritional status 2
T1: baseline(Data were collected before the intervention). T2: 4 weeks. T3:8 weeks.
Nutritional status 3
T1: baseline(Data were collected before the intervention). T2: 4 weeks. T3:8 weeks.
- +1 more secondary outcomes
Study Arms (2)
Routine care group
NO INTERVENTIONThe control group receives routine nursing, including admission education, routine nursing of adverse reactions to chemotherapy, diet guidance for chemotherapy patients, precautions for various examinations, discharge guidance and follow-up.
Auricular point sticking group
EXPERIMENTALAuricular point sticking therapy is performed on the basis of control group. The acupoint intervention group is established, and the research team consists of 2 graduate students, 1 graduate supervisor, 1 head nurse, 1 chief physician of traditional Chinese medicine, and 1 nursing expert. The nursing expert is responsible for the overall design of the project, and the director of traditional Chinese medicine is responsible for the selection of acupoints and the training of nurses for massage. The supervisor of graduate students and the head nurse are responsible for the overall quality control of the intervention process, while the graduate students are responsible for the preliminary and final screening of research objects, the implementation of intervention programs, the organization, coordination and recording of the entire intervention process and the collection of data.
Interventions
1. Acupoint selection: Select Shenmen, spleen, stomach, liver, sympathetic, tongue, digestive system under the cortex, three focal, ear-back spleen. 2. Operation: Use 75% ethanol to disinfect auricular broad skin; To be dry, use tweezers to pick up the middle of the small square tape stuck with Wang do not line seeds, align the indentation and stick well, press gently with the finger abdomen, the strength to the patient feel acid swelling, pain and heat sense and can tolerate it. 3. Press frequency and course of treatment: it is asked to press 4 times a day, once in the morning, middle and evening before going to bed, 3-5 minutes each time, the duration of hospitalization for patients with chemotherapy is generally 3-5 days, intervention begins on the first day of chemotherapy medication, the day of discharge for patients to replace the other side of the ear acupoint, removed after 4 days of discharge. A total of 2 chemotherapy courses were treated.
Eligibility Criteria
You may qualify if:
- Patients with malignant tumors diagnosed by histopathology or pathology;
- Age ≥18 years old;
- Patients who received platinum-based chemotherapy and completed at least one cycle of chemotherapy;
- According to the chemotherapy-induced taste Changes Scale (CiTAS), the score of patients was ≥6;
- Patients voluntarily participated in the treatment with good compliance and adherence.
You may not qualify if:
- Patients with treatment plan adjustment or concurrent radiotherapy;
- Patients with abnormal taste and malnutrition caused by various reasons before chemotherapy;
- Patients with inflammation of the external ear or eczema, ulcers, chilblain in the pressing area;
- Allergic or intolerant to adhesive stickers;
- Those who were lost to follow-up or withdrew voluntarily;
- Patients enrolled in other studies at the same time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Quan Liu, Doctor
Affiliated Hospital of Jiangnan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2023
First Posted
May 22, 2023
Study Start
June 3, 2023
Primary Completion
September 30, 2023
Study Completion
December 30, 2023
Last Updated
January 31, 2024
Record last verified: 2024-01